We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXLS:NASDAQExlService Holdings, Inc. Analysis

Data as of 2026-07-18 - not real-time

$28.16

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ExlService is trading at $28.16, well beneath its 20‑day ($26.90), 50‑day ($28.29) and 200‑day ($34.61) simple moving averages, signaling a short‑term bearish bias. The RSI sits around 53, indicating neutral momentum, while the MACD histogram is positive, hinting at a tentative bullish reversal. Volume has been trending down, which may limit upside momentum until the next catalyst, notably the Q2 earnings release slated for July 28. Fundamentally, the company shows a 13.8% revenue growth rate, solid operating margins (~16%), and a ROE near 28%, all at a trailing PE of 18—well below the industry average of 33—suggesting relative value. The discounted cash‑flow model estimates a fair value of $42.94, implying roughly 42% upside, and the forward PE of 11 reinforces the growth narrative. However, the stock’s 30‑day volatility exceeds 40% and beta is low (~0.25), indicating price swings are driven more by company‑specific factors than market moves. With no dividend and a debt‑to‑equity of ~67%, cash generation remains critical, but free cash flow of $295 M supports the balance sheet.
Overall, the blend of undervaluation, strong cash flow, and a favorable growth outlook makes EXLS a compelling medium‑ to long‑term buy, while near‑term traders should remain cautious given the bearish technical backdrop and diminishing volume.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below multiple moving averages indicating bearish bias
  • Decreasing volume limiting short‑term price support
  • MACD histogram positive but weak, suggesting limited upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value $42.94 versus market $28.16 (~42% upside)
  • Revenue growth of 13.8% and strong operating margins
  • Forward PE of 11, far below industry average, indicating growth potential

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained cash generation with free cash flow > $295 M
  • Low beta and high ROE (≈28%) supporting defensive characteristics
  • Expanding AI and data services market providing secular growth tailwinds

Key Metrics & Analysis

Financial Health

Revenue Growth13.80%
Profit Margin11.66%
P/E Ratio18.3
ROE28.09%
ROA12.17%
Debt/Equity66.86
P/B Ratio5.5
Op. Cash Flow$349.2M
Free Cash Flow$295.2M
Industry P/E32.8

Technical Analysis

TrendBearish
RSI52.8
Support$24.85
Resistance$29.07
MA 20$26.90
MA 50$28.29
MA 200$34.61
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair Value$42.94
Target Price$40.13
Upside/Downside42.49%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.26
Volatility41.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.